Concepedia
Statistics
Publications
6
Citations
224
H-Index
Active since
2001
Affiliations
Queen Mary University of London(Current)
The Christie NHS Foundation Trust
Addenbrooke's Hospital
University Hospitals of North Midlands NHS Trust
Leeds Teaching Hospitals NHS Trust
Michael J. Austin is an author at Queen Mary University of London specializing in chemotherapy, medicine, and molecular oncology.
Publications per year
2001–2024
Molecular MRD is strongly prognostic in patients with <i>NPM1</i>-mutated AML receiving venetoclax-based nonintensive therapy
Jad Othman, Ing Soo Tiong, Jenny O’Nions et al. · Blood · 2023 · 65 citations · Full text
Medicine, Hematology, Oncology +14
Toward Financially Viable Phytoextraction and Production of Plant-Based Palladium Catalysts
Zakuan Azizi Shamsul Harumain, Helen L. Parker, Andrea Muñoz García et al. · Environmental Science & Technology · 2017 · 51 citations · Full text
Natural Sciences, Botany, Plant Sciences +14
Adipocytes disrupt the translational programme of acute lymphoblastic leukaemia to favour tumour survival and persistence
Quentin Heydt, Chrysi Xintaropoulou, Andrew Clear et al. · Nature Communications · 2021 · 39 citations · Full text
Medicine, Cell Biology, Oncology +17
Real-world outcomes of newly diagnosed AML treated with venetoclax and azacitidine or low-dose cytarabine in the UK NHS
Jad Othman, Ho Pui Jeff Lam, Sarah Leong et al. · Blood Neoplasia · 2024 · 36 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +11
Stearoyl-CoA desaturase inhibition is toxic to acute myeloid leukemia displaying high levels of the de novo fatty acid biosynthesis and desaturation
Vilma Dembitz, Hannah Lawson, Richard Burt et al. · Leukemia · 2024 · 22 citations · Full text
Medicine, Cancer Biology, Oncology +17
1–5 of 6